3rd International Conference on Immunology and Vaccines
November 7-9, 2018   Tokyo, Japan

Guidelines

ImmunoVaccine-2018 conference is one of the interesting educational and scientific events in the medical science. The program is well designed by the conference committee which includes plenary lectures, oral sessions, poster sessions and symposia/workshops.

Target Audience:

Vaccinologists/Immunologists, Academicians, Scientists, Researchers and Students
Vaccines Training Institutes
Manufacturing Medical Device Companies
Drug Investigators & Developers
Immunology and Vaccines Associations and Societies
Business Entrepreneurs
Doctors

Abstract Submission Guidelines:

• Title of the abstract must be in sentence case. The title must represent the abstract content.

• Name of the author and co-authors (if present). You may list up to 20 individual authors for each abstract.

• Provide your full name, degree, institution, address, telephone number, and email address. (Email address of the main author/presenter).

• Abstract content must not exceed 300 words. The body of the abstract should describe your research, results and conclusions of your study.

• A short biography of 100 words of the main author/presenter must be included along with abstract.

• All the abstracts must be submitted before the deadlines provided.

• Abstract will be reviewed by the committee and you will receive an e-mail notification within 24-48 hours of abstract submission.

For the sample template of the abstract, please click here

Complete the form and send us your queries at immunovaccine@madridge.com

ImmunoVaccine-2018 Abstract Submission starts from January 20, 2018. All the abstracts should be submitted through online abstract submission or can be mailed at immunovaccine@madridge.com